Learn More
R&D Systems™ Recombinant Human Latent TGF-beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 299-LT-005
Description
The Recombinant Human Latent TGF-beta 1 Protein is derived from CHO. The Recombinant Human Latent TGF-beta 1 Protein has been validated for the following applications: Bioactivity.
Specifications
Supplied as a 0.2μm filtered solution in PBS and Glycerol with BSA as a carrier protein. | |
Observed Molecular Wt: 40-43kDa & 12kDa, reducing conditions 80-90kDa, non-reducing conditions, Predicted Molecular Wt.: 41.3kDa (monomer) | |
5 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, ≤ -20° C under sterile conditions after opening. | |
<1.0 EU per 1μg of the protein by the LAL method. | |
Unconjugated | |
97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
7040 | |
Latent TGF-beta 1 | |
Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Leu30-Ser390 | |
Leu30 & Ala279 | |
CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 | |
Recombinant |
Product Suggestions
Customers who viewed this item also viewed
Your input is important to us. Please complete this form to provide feedback related to the content on this product.